IC
PCVX icon

Ikarian Capital’s Vaxcyte PCVX Stock Holding History

Ikarian Capital’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,000
Closed -$252K – 208
2025
Q3 		$252K Buy
7,000
+100
+1% +$3.31K 0.03% 147
2025
Q2 		$224K Buy
+6,900
New +$226K 0.04% 110

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ikarian Capital's PCVX Position: Q1 2026 in Review

Ikarian Capital increased its Vaxcyte (PCVX) stake by 13% in Q1 2026, buying an estimated $2.71M and bringing the position to 428,682 shares worth $24.9M. The position accounts for 2.02% of the portfolio, ranked #12.

Ikarian Capital first reported a position in PCVX in Q2 2020 and has held it in 18 quarters since. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • Ikarian Capital held 428,682 shares of Vaxcyte worth $24.9M as of Q1 2026.
  • Ikarian Capital bought 50,000 Vaxcyte shares in Q1 2026, an estimated $2.71M.
  • Vaxcyte made up 2.02% of Ikarian Capital's portfolio in Q1 2026, its #12 holding.
  • Ikarian Capital first reported a position in Vaxcyte in Q2 2020 and has held it in 18 quarters since.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.